PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,706 stories, page 568 of 729

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Valve Strands in Patients With Infective Endocarditis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Cofactor functions of magnesium in complement activation and antimicrobial responses

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Neonatal genetic sequencing as a first-tier option: a real-world clinical implementation study in Northern China

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Agentic AI-driven closed-loop analytical systems for autonomous pharmaceutical method development and regulatory-aware analysis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Extracellular synthesis of CeNPs and ZnNPs using thermophilic Anoxybacillus flavithermus and Geobacillus stearothermophilus bacteria, and their biological activities

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Breast Conserving Therapy Versus Mastectomy: Outcomes Across Different Clinical Characteristics

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Active recruitment for vaccination of patients with solid-organ cancer through the surgical pathway

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Deciphering B cell Maturation Dynamics in Hyper-IgM Syndromes

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

From competence to entrustment: strengthening clinical autonomy within the ESICM educational framework

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Domain Knowledge Guided for Varicose Vein Classification with Adaptive Clinical Experts

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Diagnostic Pitfalls of Action‐Induced Tremor: A Case Report of Benign Adult Familial Myoclonic Epilepsy Treated with Thalamic Lesioning

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Mental Health and Serious Drug Crime: A Case–Control Study

CrossrefOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07694219: Bowen Therapy and McGill Stabilization Exercises in Chronic Low Back Pain

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07692347: Global Myofascial Treatment With Focused Shockwave for Non-Specific Low Back Pain: a Randomized Control Trial.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07692230: MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07691801: Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07691515: A Phase III Trial of Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07669363: Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07640191: Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07629440: A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07619495: Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07571109: AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07567846: A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07545317: Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07540988: FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07525167: Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07520734: Clinical Outcomes After Laser Hemorrhoidoplasty

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07421167: A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07243925: Effect of Family Participation-Based Intervention Before Coronary Artery Bypass Grafting (CABG) on Patients' Anxiety, Independence, and Psychological Resilience: A Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07161414: A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06917209: Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06483139: Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06149481: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05412212: Brief Educational Video for Patients Prescribed LTBI Treatment

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05335876: Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05143957: A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04439201: Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03834493: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03192267: Early Rheumatoid Arthritis Lung Disease Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03000244: Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02977299: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01883505: A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA plans rules to rein in drug ads, enable proactive release of CRLs, and more

RAPSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

The Motley FoolOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Sector Plan: One Year On

Progress report on delivering the Life Sciences Sector Plan.

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Sector Plan

The Life Sciences Sector Plan sets out a vision and an action plan to drive growth, innovation, and...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

UK life sciences attracts £3bn investment, creating jobs and faster patient treatments

Life Sciences sector attracts over £3 billion in new public-private investment in 12 months, reflect...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Organ-on-a-chip, Organoids, but Drug Testing on Whole Organs? This Startup is Betting On It

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Local biotech companies may get option to report finances twice a year

KALWOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rhythm Pharmaceuticals Announces NEJM Publication of Phase 3 TRANSCEND Trial Results for Setmelanotide in Acquired Hypothalamic Obesity

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rhythm’s obesity drug data lands in NEJM after 52-week Phase 3 trial

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial

respiratory-therapy.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA unveils 3-year blueprint to expand drug development for minor uses and minor species

DVM360Original source
🌍discoverynews.google.comTier 3 · Aggregated media

New York pushes to become major US biotech hub

BioProcess InternationalOriginal source
🇺🇸Industryinvestors.amneal.comTier 1 · Company source

Amneal and Adalvo Announce FDA Acceptance for Review of Two U.S. ANDAs for Generic Tirzepatide Autoinjector

Amneal Pharmaceuticals RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

$180M financing supports head-to-head Phase 3 IPF drug trial

Pulmonary Fibrosis NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Alector (ALEC) sees GSK end antibody collaboration while repaying $10.4M loan

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tarsus pays $75M for eye drug candidate with Phase 3 ahead

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI as Reinvention | PharmExec

Pharmaceutical ExecutiveOriginal source